| Terminal complement inhibitor eculizumab in atypical hemolytic–uremic syndrome CM Legendre, C Licht, P Muus, LA Greenbaum, S Babu, C Bedrosian, ... New England Journal of Medicine 368 (23), 2169-2181, 2013 | 1608 | 2013 |
| Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults V Fremeaux-Bacchi, F Fakhouri, A Garnier, F Bienaimé, ... Clinical Journal of the American Society of Nephrology 8 (4), 554-562, 2013 | 787 | 2013 |
| Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft Recipients12 H Kreis, JM Cisterne, W Land, L Wramner, JP Squifflet, D Abramowicz, ... Transplantation 69 (7), 1252-1260, 2000 | 693 | 2000 |
| The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high‐risk kidney transplant recipients A Humar, Y Lebranchu, F Vincenti, EA Blumberg, JD Punch, AP Limaye, ... American Journal of Transplantation 10 (5), 1228-1237, 2010 | 537 | 2010 |
| Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells L de Beaucoudrey, A Puel, O Filipe-Santos, A Cobat, P Ghandil, ... The Journal of experimental medicine 205 (7), 1543-1550, 2008 | 498 | 2008 |
| Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study S Choquet, V Leblond, R Herbrecht, G Socié, AM Stoppa, ... Blood 107 (8), 3053-3057, 2006 | 493 | 2006 |
| Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey MO Chandesris, I Melki, A Natividad, A Puel, C Fieschi, L Yun, ... Medicine 91 (4), e1-e19, 2012 | 330 | 2012 |
| Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study Y Lebranchu, A Thierry, O Toupance, PF Westeel, I Etienne, E Thervet, ... American Journal of Transplantation 9 (5), 1115-1123, 2009 | 302 | 2009 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 300 | 2017 |
| Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy Y Lebranchu, F Bridoux, M Büchler, Y Le Meur, I Etienne, O Toupance, ... American Journal of Transplantation 2 (1), 48-56, 2002 | 295 | 2002 |
| Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population JM Halimi, B Giraudeau, E Cacès, H Nivet, Y Lebranchu, J Tichet Kidney international 58 (3), 1285-1292, 2000 | 262 | 2000 |
| Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. B Khalfoun, F Thibault, H Watier, P Bardos, Y Lebranchu Advances in experimental medicine and biology 400, 589-597, 1997 | 252 | 1997 |
| DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1 Y Vanrenterghem, Y Lebranchu, R Hené, F Oppenheimer, H Ekberg, ... Transplantation 70 (9), 1352-1359, 2000 | 249 | 2000 |
| Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway C Hoarau, C Lagaraine, L Martin, F Velge-Roussel, Y Lebranchu Journal of Allergy and Clinical Immunology 117 (3), 696-702, 2006 | 248 | 2006 |
| Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression1 G Mourad, V Garrigue, JP Squifflet, T Besse, F Berthoux, E Alamartine, ... Transplantation 72 (6), 1050-1055, 2001 | 220 | 2001 |
| Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus SM Wellicome, P Kapahi, JC Mason, Y Lebranchu, H Yarwood, ... Clinical & Experimental Immunology 92 (3), 412-418, 1993 | 204 | 1993 |
| Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6‐month course of steroids M Büchler, S Caillard, S Barbier, E Thervet, O Toupance, H Mazouz, ... American Journal of Transplantation 7 (11), 2522-2531, 2007 | 199 | 2007 |
| A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant … B Charpentier, L Rostaing, F Berthoux, P Lang, G Civati, JL Touraine, ... Transplantation 75 (6), 844-851, 2003 | 198 | 2003 |
| One-year results of the effects of rituximab on acute antibody-mediated rejection in renal transplantation: RITUX ERAH, a multicenter double-blind randomized placebo-controlled … B Sautenet, G Blancho, M Büchler, E Morelon, O Toupance, B Barrou, ... Transplantation 100 (2), 391-399, 2016 | 196 | 2016 |
| Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas S Caillard, FX Lamy, C Quelen, J Dantal, Y Lebranchu, P Lang, M Velten, ... American Journal of Transplantation 12 (3), 682-693, 2012 | 191 | 2012 |
